SS
Samantha Semenkow Citigroup Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
25
Avg Return
Past Year
Past Year
12%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
78.6%
Neutral
14.3%
Negative
7.1%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Initiated
| $102 |
79%
upside
| 1 | -5.3% |
0
%
| 26 Nov ‘25 7 days ago |
|
|
|
Buy
Initiated
| $38 |
38%
upside
| 1 | -3.3% |
0
%
| 26 Nov ‘25 7 days ago |
|
|
|
Buy
Initiated
| $136 |
30%
upside
| 1 | -1.8% |
0
%
| 25 Nov ‘25 9 days ago |
|
|
|
Buy
Maintained
| $1,124 |
22%
upside
| 1 | +19% |
0
%
| 17 Nov ‘25 17 days ago |
|
|
|
Buy
Maintained
| $14 |
54%
upside
| 2 | -13% |
0
%
| 13 Nov ‘25 20 days ago |
|
|
|
Neutral
Maintained
| $4.25 |
18%
upside
| 1 | – |
–
| 11 Nov ‘25 22 days ago |
|
|
|
Buy
Maintained
| $26 |
26%
upside
| 2 | +22% |
0
%
| 11 Nov ‘25 22 days ago |
|
|
|
Buy
Maintained
| $33 |
43%
upside
| 1 | +10% |
0
%
| 7 Nov ‘25 26 days ago |
|
|
|
Buy
Maintained
| $15 |
63%
upside
| 2 | +33% |
0
%
| 29 Oct ‘25 1 month ago |
|
|
|
Sell
Downgraded
| $5 |
63%
downside
| 2 | -36% |
0
%
| 29 Oct ‘25 1 month ago |
|